Oncogene Science Inc. has appointed Alan Higgins director ofdrug development. He was previously director ofcardiovascular research at Hoffmann-LaRoche, New Jersey.
Immulogic Pharmaceutical Corp. has appointed Robert Geretyto the new position of executive vice president, pharmaceuticaloperations. He will oversee three research groups as well asmedical, regulatory and development functions.
RiboGene Inc. has appointed Kenneth Ludlum vice president,finance and administration, and chief financial officer. Hejoined RiboGene from Alteon Inc.
(c) 1997 American Health Consultants. All rights reserved.